News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma
Jan 21, 2025, 15:29

Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared an article by Wan-Qin Chong on X:

“Randomized phase II study in The Lancet Oncology shows that adding bevacizumab to pembrolizumab in previously treated nasopharygeal carcinoma improves RR (58.3% vs 12.5%) and significantly increased PFS to 13.8m from 1.6m: HR 0.25!”

Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial.

Authors: Wan-Qin Chong, et al.

Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma

More posts featuring Stephen V Liu.

Bevacizumab cancer fight against cancer Georgetown University Global fight against cancer OncoDaily Oncology pembrolizumab The Lancet Oncology Wan-Qin Chong
Special Coverage
Blog
Jan 21, 2025, 15:29
Judy Medeiros Fitzgerald: Unconventional Paths to Healing - A Cancer Survivor's Journey Through Complementary and Alternative Medicine
Science
Jan 21, 2025, 15:29
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma
Insight
Jan 21, 2025, 15:07
FDA's Project Optimus: Paving the Way for Precision Dosing in Oncology
Insight
Jan 21, 2025, 14:54
Douglas R. Lowy has been appointed as the New Acting Director of National Cancer Institute
Blog
Jan 21, 2025, 14:49
Nwamaka Lasebikan: Strengthening Nigeria's Oncology Workforce
Dialogues
Jan 21, 2025, 14:48
Clinical Trials in Small Populations: Challenges and Opportunities
Blog
Jan 21, 2025, 14:25
Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR
Blog
Jan 21, 2025, 14:19
2 days left for the 17th BGICC in Cairo - ORWA Managment Consulting
Science
Jan 21, 2025, 14:15
Distinct molecular and clinical features of KRAS G12 mutations in Pancreatic Cancer
Insight
Jan 21, 2025, 14:12
Myeloma Paper of the Day, January 21st, suggested by Robert Orlowski
Blog
Jan 21, 2025, 14:12
Pashtoon Kasi about targeting BRAFV600E in Colorectal Cancer
Blog
Jan 21, 2025, 14:11
Ibrahim Halil Sahin: ctDNA and its role on future management of early stage colon cancer